Tuesday, April 17, 2012
Cyclacel Pharmaceuticals Announces Grant of New U.S. Patent Covering Sapacitabine
(
CYCC
,
News
,
FDA
/ Tue, 07:04am)
Monday, February 13, 2012
Cyclacel Provides Update on Clinical Progress With Sapacitabine as Second Line Therapy in Older Patients With Myelodysplastic Syndromes
(
CYCC
,
News
,
FDA
/ Mon, 08:00am)
Wednesday, January 11, 2012
Cyclacel Provides Corporate Update at OneMedForum Conference; Re-Analysis "Insufficient"
(
ATM
,
CLL
,
CYCC
,
News
,
SPA
,
FDA
/ Wed, 01:27pm)
Monday, December 12, 2011
Updated Results From Cyclacel Clinical Study Highlight Safety and Efficacy of Sequential Administration of Sapacitabine and Decitabine in Elderly Patients With AML
(
ASH
,
CYCC
,
News
,
FDA
/ Mon, 02:02pm)
Wednesday, December 07, 2011
Cyclacel Provides Update on Clinical Progress With Sapacitabine in Solid Tumors Including Activity in BRCA Mutation-Positive Patients
(
CYCC
,
CYCCP
,
News
,
FDA
/ Wed, 08:02am)
Thursday, October 13, 2011
Cyclacel Announces Data Safety Monitoring Board Recommendation to Continue the SEAMLESS Phase 3 Trial of Sapacitabine
(
CYCC
,
News
,
FDA
/ Thu, 07:05am)
Monday, August 15, 2011
Hearing Cyclacel Pharma Drug Effective on Breast Cancer Tumors
(
CYCC
,
News
,
Rumors
,
FDA
,
Movers
/ Mon, 10:33am)
Monday, July 18, 2011
Cyclacel Pharmaceuticals Amends Its Sapacitabine License Agreement With Daiichi-Sankyo
(
CYCC
,
News
,
FDA
/ Mon, 07:01am)